Soleus Capital Management, L.P. Essa Pharma Inc. Transaction History
Soleus Capital Management, L.P.
- $1.22 Billion
- Q1 2024
A detailed history of Soleus Capital Management, L.P. transactions in Essa Pharma Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 3,589,558 shares of EPIX stock, worth $17.2 Million. This represents 2.49% of its overall portfolio holdings.
Number of Shares
3,589,558
Previous 4,327,622
17.05%
Holding current value
$17.2 Million
Previous $28.6 Million
6.7%
% of portfolio
2.49%
Previous 3.68%
Shares
18 transactions
Others Institutions Holding EPIX
# of Institutions
36Shares Held
35MCall Options Held
53.4KPut Options Held
29.4K-
Bvf Inc San Francisco, CA8.75MShares$41.8 Million2.22% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.89MShares$37.7 Million1.05% of portfolio
-
Morgan Stanley New York, NY4.18MShares$20 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.98MShares$14.2 Million1.25% of portfolio
-
Rtw Investments, LP New York, NY2.3MShares$11 Million0.31% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $211M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...